当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:55.42亿  总市值:76.57亿
流通股本:4.24亿   总股本:5.86亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.06亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益388549.30万元,未分配利润257383.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产518326.12万元,负债129776.83万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入334,810,688.091,355,507,324.471,011,713,943.43668,335,957.13
营业总成本217,562,849.44929,773,807.64694,610,808.39461,501,647.18
其他经营收益
营业利润123,942,303.12235,982,871.91307,842,002.72196,826,910
利润总额123,984,338.47236,252,138.82306,960,707.65196,384,262.15
净利润105,611,273190,537,287.77273,070,841.15175,713,965.16
每股收益
其他综合收益-338,607.92-495,498.1-233,627.67-89,167.78
综合收益总额105,272,665.08190,041,789.67272,837,213.48175,624,797.38
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,348,546,132.612,199,691,700.262,429,825,802.082,447,221,182.22
非流动资产:
非流动资产合计2,834,715,101.532,852,739,493.232,865,220,909.022,994,802,970.28
资产总计5,183,261,234.145,052,431,193.495,295,046,711.15,442,024,152.5
流动负债:
流动负债合计192,869,548.95171,316,477.4208,320,430.35208,697,977.56
非流动负债:
非流动负债合计1,104,898,705.781,098,254,997.761,091,493,781.231,160,540,629.7
负债合计1,297,768,254.731,269,571,475.161,299,814,211.581,369,238,607.26
所有者权益(或股东权益):
归属于母公司股东权益合计3,891,389,331.113,788,015,483.724,000,375,714.954,078,022,542.14
股东权益合计3,885,492,979.413,782,859,718.333,995,232,499.524,072,785,545.24
负债和股东权益合计5,183,261,234.145,052,431,193.495,295,046,711.15,442,024,152.5
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计342,020,999.721,615,329,769.151,209,072,997.52798,356,728.95
经营活动现金流出小计246,514,762.961,050,220,018.18782,239,426.33554,280,078.23
经营活动产生的现金流量净额95,506,236.76565,109,750.97426,833,571.19244,076,650.72
投资活动产生的现金流量:
投资活动现金流入小计50,330,70073,632,641.2743,724,876.2743,153,085.71
投资活动现金流出小计9,107,025.68548,952,695.86293,312,420.48236,083,794.81
投资活动产生的现金流量净额41,223,674.32-475,320,054.59-249,587,544.21-192,930,709.1
筹资活动产生的现金流量:
筹资活动现金流入小计355,177.097,489,413.956,168,419.444,433,931.57
筹资活动现金流出小计3,190,683.94688,302,660.31570,488,806.53285,229,023.7
筹资活动产生的现金流量净额-2,835,506.85-680,813,246.36-564,320,387.09-280,795,092.13
汇率变动对现金及现金等价物的影响-194,057.48-389,715.5-164,996.95-72,861.86
现金及现金等价物净增加额133,700,346.75-591,413,265.48-387,239,357.06-229,722,012.37
期末现金及现金等价物余额673,345,483.11539,645,136.36743,819,044.78901,336,389.47
补充资料:
现金及现金等价物的净增加额--591,413,265.48--229,722,012.37
最新报告期:2026-05-02
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中泰证券祝嘉琦,谢木青0.730.840.952026-05-02
光大证券黎一江0.680.871.042026-04-29
TOP↑